Related Experiment Video

Updated: May 21, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

587

Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer

Abdulmalik Saleh Alfawaz Altamimi1, M Arockia Babu2, Muhammad Afzal3

  • 1Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Al Kharj, Saudi Arabia.

Medical Oncology (Northwood, London, England)
|March 18, 2025
PubMed

Insights

Natural killer cell-derived exosomes (NK-Exos) show potential as cancer immunotherapeutics by delivering cytotoxic molecules to tumor cells. Bioengineered NK-Exos enhance anti-cancer effects and synergize with other treatments.

Area of Science:

  • Immunology
  • Oncology
  • Nanomedicine

Background:

  • Natural killer cell-derived exosomes (NK-Exos) are potent immune modulators with inherent anti-tumor properties.
  • These nanosized vesicles deliver cytotoxic payloads like perforin, granzymes, and miRNAs directly to cancer cells, bypassing immune suppression.
  • NK-Exos are particularly effective against aggressive breast cancer by modulating the tumor microenvironment (TME) to stimulate immune responses and reduce immunosuppression.

Purpose of the Study:

  • To review the therapeutic potential of NK-Exos in cancer treatment, focusing on breast cancer.
  • To highlight the role of bioengineered NK-Exos in enhancing targeted delivery and therapeutic payloads.
  • To explore the synergistic effects of NK-Exos in combination therapies and discuss future research directions.

Main Methods:

  • Review of existing literature on NK-Exos in cancer therapy.
  • Analysis of bioengineering strategies for NK-Exos modification.
  • Evaluation of NK-Exos efficacy in preclinical models and combination therapies.

Main Results:

  • Engineered NK-Exos demonstrate enhanced cancer cell apoptosis, reduced tumor growth, and overcome drug resistance.
  • NK-Exos effectively modulate the TME to promote anti-tumor immunity.
  • Combination of NK-Exos with radiotherapy, chemotherapy, or checkpoint inhibitors shows synergistic therapeutic effects and reduced toxicity.

Conclusions:

  • NK-Exos represent a promising cell-free immunotherapeutic strategy for cancer, especially breast cancer.
  • Bioengineering significantly expands the therapeutic capabilities of NK-Exos for targeted delivery and payload optimization.
  • Further research is crucial to address limitations and translate the clinical potential of NK-Exos in combination therapies.
Keywords:
Breast cancerCancer immunotherapyExosomesExtracellular vesiclesNatural killer cells

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

24.8K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
821